Neogen Chemicals Past Earnings Performance
Past criteria checks 1/6
Neogen Chemicals has been growing earnings at an average annual rate of 13.4%, while the Chemicals industry saw earnings growing at 16.8% annually. Revenues have been growing at an average rate of 23.6% per year. Neogen Chemicals's return on equity is 4.7%, and it has net margins of 5.2%.
Key information
13.4%
Earnings growth rate
10.0%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 23.6% |
| Return on equity | 4.7% |
| Net Margin | 5.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Earnings Miss: Neogen Chemicals Limited Missed EPS By 24% And Analysts Are Revising Their Forecasts
May 05
After Leaping 27% Neogen Chemicals Limited (NSE:NEOGEN) Shares Are Not Flying Under The Radar
Apr 26Are Neogen Chemicals Limited (NSE:NEOGEN) Investors Paying Above The Intrinsic Value?
Apr 12Neogen Chemicals (NSE:NEOGEN) Is Increasing Its Dividend To ₹2.75
Aug 11Neogen Chemicals Limited (NSE:NEOGEN) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 10Here's Why I Think Neogen Chemicals (NSE:NEOGEN) Is An Interesting Stock
Feb 09Neogen Chemicals' (NSE:NEOGEN) Returns On Capital Not Reflecting Well On The Business
Sep 21Neogen Chemicals' (NSE:NEOGEN) Dividend Will Be Increased To ₹2.25
Sep 05Neogen Chemicals (NSE:NEOGEN) Will Pay A Larger Dividend Than Last Year At ₹2.25
Aug 11Does Neogen Chemicals (NSE:NEOGEN) Deserve A Spot On Your Watchlist?
Jun 04Should You Think About Buying Neogen Chemicals Limited (NSE:NEOGEN) Now?
May 24Neogen Chemicals (NSE:NEOGEN) May Have Issues Allocating Its Capital
Apr 05Is Neogen Chemicals Limited's(NSE:NEOGEN) Recent Stock Performance Tethered To Its Strong Fundamentals?
Mar 07Should You Buy Neogen Chemicals Limited (NSE:NEOGEN) For Its Dividend?
Feb 21
Does Neogen Chemicals (NSE:NEOGEN) Have A Healthy Balance Sheet?
Jan 26Could The Neogen Chemicals Limited (NSE:NEOGEN) Ownership Structure Tell Us Something Useful?
Jan 13The Returns At Neogen Chemicals (NSE:NEOGEN) Provide Us With Signs Of What's To Come
Dec 31Don't Ignore The Fact That This Insider Just Sold Some Shares In Neogen Chemicals Limited (NSE:NEOGEN)
Dec 18Neogen Chemicals Limited (NSE:NEOGEN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Dec 07If You Had Bought Neogen Chemicals (NSE:NEOGEN) Shares A Year Ago You'd Have Earned 70% Returns
Nov 23Revenue & Expenses BreakdownBeta
How Neogen Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 6,907 | 357 | 620 | 0 |
| 31 Dec 23 | 6,949 | 330 | 662 | 0 |
| 30 Sep 23 | 7,168 | 467 | 617 | 0 |
| 30 Jun 23 | 7,032 | 486 | 499 | 0 |
| 31 Mar 23 | 6,862 | 500 | 529 | 0 |
| 31 Dec 22 | 6,391 | 513 | 448 | 0 |
| 30 Sep 22 | 5,855 | 471 | 410 | 0 |
| 30 Jun 22 | 5,505 | 484 | 353 | 0 |
| 31 Mar 22 | 4,873 | 446 | 334 | 0 |
| 31 Dec 21 | 4,231 | 383 | 281 | 0 |
| 30 Sep 21 | 3,757 | 364 | 250 | 0 |
| 30 Jun 21 | 3,445 | 326 | 215 | 0 |
| 31 Mar 21 | 3,364 | 313 | 209 | 0 |
| 31 Dec 20 | 3,260 | 293 | 221 | 0 |
| 30 Sep 20 | 3,231 | 290 | 216 | 0 |
| 30 Jun 20 | 3,183 | 293 | 180 | 0 |
| 31 Mar 20 | 3,061 | 287 | 200 | 0 |
| 31 Dec 19 | 3,036 | 301 | 195 | 0 |
| 30 Sep 19 | 2,846 | 262 | 180 | 0 |
| 30 Jun 19 | 2,555 | 225 | 152 | 0 |
| 31 Mar 19 | 2,391 | 209 | 142 | 0 |
| 31 Mar 18 | 1,612 | 110 | 108 | 0 |
| 31 Mar 17 | 1,101 | 77 | 71 | 0 |
| 31 Mar 16 | 1,003 | 52 | 59 | 0 |
| 31 Mar 15 | 839 | 51 | 59 | 0 |
| 31 Mar 14 | 738 | 36 | 45 | 0 |
Quality Earnings: NEOGEN has a high level of non-cash earnings.
Growing Profit Margin: NEOGEN's current net profit margins (5.2%) are lower than last year (7.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEOGEN's earnings have grown by 13.4% per year over the past 5 years.
Accelerating Growth: NEOGEN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NEOGEN had negative earnings growth (-28.7%) over the past year, making it difficult to compare to the Chemicals industry average (-4.7%).
Return on Equity
High ROE: NEOGEN's Return on Equity (4.7%) is considered low.